Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Frederick Charles Morgan, M.D.

Concepts (73)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Carcinoma, Basal Cell620245591.400 Why?
Skin Neoplasms15202457991.180 Why?
Papilloma120221410.750 Why?
Hamartoma Syndrome, Multiple120221140.740 Why?
Vascular Malformations120224640.530 Why?
Carcinoma, Squamous Cell6202240240.490 Why?
Mohs Surgery420242210.330 Why?
Health Expenditures2201823620.320 Why?
Dermatology420219140.300 Why?
Neoplasm Recurrence, Local6202392760.280 Why?
Skin1201944660.260 Why?
Health Care Costs1201832580.240 Why?
Melanoma2202256970.230 Why?
Early Detection of Cancer1201832020.220 Why?
Hyphae12021520.190 Why?
Nervous System Neoplasms12020910.170 Why?
Epidermis120215290.160 Why?
Lip Neoplasms12018360.150 Why?
Internship and Residency3202158700.140 Why?
Antifungal Agents120217490.140 Why?
Immunocompromised Host120218570.130 Why?
PTEN Phosphohydrolase1202211150.130 Why?
Neoplasm Staging32021111520.130 Why?
Neoplasm Invasiveness3202036180.130 Why?
Medicare3201867860.130 Why?
Cancer Care Facilities120184240.120 Why?
Retrospective Studies122023803720.120 Why?
Tumor Burden1201918950.110 Why?
Academic Medical Centers3201827540.110 Why?
Brachytherapy1201912380.100 Why?
Physicians, Primary Care120186240.090 Why?
Lymphatic Metastasis1201829430.090 Why?
Cohort Studies52022413350.070 Why?
Hospitals1202139280.070 Why?
Humans2020247606210.070 Why?
Risk Assessment42020241230.060 Why?
Massachusetts1201888030.060 Why?
Patient Selection1201642830.060 Why?
Female1120243912700.060 Why?
Head and Neck Neoplasms1201828820.050 Why?
Aged820241691520.050 Why?
Male1020243597440.050 Why?
Prognosis12021296580.040 Why?
Treatment Outcome32024650170.040 Why?
Personnel Selection120211930.040 Why?
Follow-Up Studies12019392610.040 Why?
Quality of Life12019133080.040 Why?
Disease-Free Survival2201868280.040 Why?
Sex Factors22024105470.040 Why?
Cross-Sectional Studies12018259420.040 Why?
Middle Aged620242203520.030 Why?
Preoperative Period120195550.030 Why?
United States62021724610.030 Why?
Lip120181970.030 Why?
Survival Analysis22018101820.030 Why?
Aged, 80 and over42024589950.030 Why?
Insurance Claim Review120177380.030 Why?
Risk Factors12019743590.030 Why?
Biopsy, Needle1201716300.030 Why?
Reoperation1201642910.020 Why?
Evidence-Based Medicine1201636960.010 Why?
Immunohistochemistry12017110710.010 Why?
Adult420192199940.010 Why?
Socioeconomic Factors1201778060.010 Why?
Survival Rate12017128080.010 Why?
Sensitivity and Specificity12018146600.010 Why?
Databases, Factual1201780350.010 Why?
Age Factors12017184160.010 Why?
Incidence12018213920.010 Why?
Practice Guidelines as Topic1201674750.010 Why?
Tomography, X-Ray Computed12016205090.010 Why?
Young Adult12019587410.010 Why?
Magnetic Resonance Imaging12016362900.010 Why?
Morgan's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (73)
Explore
_
Co-Authors (8)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.